Showing results (551-560 of 1,016) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|March 16, 2023
An Informatics Bridge to Improve the Design and Efficiency of Phase I Clinical Trials for Anticancer Drug CombinationsLei Wang, Lai Wei, Shijun Zhang, et al.Cancer Research Communications|March 6, 2023
The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse ModelsShoshy A Brinch, Enya Amundsen-Isaksen, Sandra Espada, et al.Cancer Research Communications|November 16, 2022
Loss of vascular endothelial glutaminase inhibits tumor growth and metastasis, and increases sensitivity to chemotherapyVerra M Ngwa, Deanna N Edwards, Yoonha Hwang, et al.Cancer Research Communications|November 16, 2022
A ketogenic diet in combination with gemcitabine increases survival in pancreatic cancer KPC miceNatalia E Cortez, Cecilia Rodriguez Lanzi, Brian V Hong, et al.Cancer Research Communications|November 16, 2022
Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancerVan K Morris, Michael J Overman, Michael Lam, et al.Cancer Research Communications|November 17, 2022
Clinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research ConsortiumEmma Longley Barber, Siqi Chen, Mario Javier Pineda, et al.Cancer Research Communications|November 19, 2025
Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor AppearanceKenichi Suda, Yukihiro Yoshida, Hidenori Sato, et al.Cancer Research Communications|November 14, 2025
Risk Factors beyond Chemotherapy Exposure for Secondary Myeloid Neoplasms after Hematologic Cancers: A SEER-Based StudyAbhay Singh, Theresa Hahn, Rahul Mishra, et al.Cancer Research Communications|November 18, 2025
Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor PatientsVivek Subbiah, Peter P Yu, Rangaprasad Sarangarajan, et al.Cancer Research Communications|November 11, 2025
Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World StudyRuiliang Wang, Jing Xu, Chenyi Zhu, et al.Pageof 102